Carisma Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and...

Related Keywords

Oregon ,United States ,Philadelphia ,Pennsylvania ,Steven Kelly ,University Of Pennsylvania Abramson Cancer Center ,Sarah Cannon Cancer Research Institute ,City Of Hope National Medical Center ,Company Quarterly Report On Form ,Exchange Commission ,Society For Immunotherapy Of Cancer ,Carisma Therapeutics Inc ,Prnewswire Carisma Therapeutics Inc ,Drug Administration ,Company Phase ,Nasdaq ,Oregon Health Science University ,Exchange Commission On ,Fred Hutchinson Cancer Center ,Md Anderson Cancer Center ,Chief Executive Officer ,Recent Business ,Investigational New Drug Application ,Moderna Collaboration ,Pennsylvania Abramson Cancer Center ,Hope National Medical Center ,Cancer Center ,Oregon Health ,Science University ,Fred Hutchinson Cancer ,Private Securities Litigation Reform Act ,Quarterly Report ,Convertible Preferred Stock ,Stockholder Equity ,Carisma Therapeutics ,Consolidated Statements ,